|
Sign In to gain access to subscriptions and/or personal tools.
|
In vitro Modulation of T6 Expression on Gingival Langerhans Cells by Interleukin-1 Inhibitors and ETAF
L.J. Walsh
Department of Social and Preventive Dentistry, University of Queensland Dental School, Turbot Street, Brisbane, QLD 4000, Australia
P.E. Lander
Department of Social and Preventive Dentistry, University of Queensland Dental School, Turbot Street, Brisbane, QLD 4000, Australia
G.J. Seymour
Department of Social and Preventive Dentistry, University of Queensland Dental School, Turbot Street, Brisbane, QLD 4000, Australia
R.N. Powell
Department of Social and Preventive Dentistry, University of Queensland Dental School, Turbot Street, Brisbane, QLD 4000, Australia
T6 antigen is a highly specific marker for human Langerhans cells (LC). Previous studies have demonstrated that Interleukin-1 (IL-1) and an IL-1 inhibitor (ILS) modulate LC T6 expression (T6E) in explant culture. The present study examined the in vitro modulation of T6E by two molecules: epidermal-cell-derived thymocyte-activating factor (ETAF), and a bone-derived protein (BP) implicated in the control of bone homeostasis. The effect of purified ILS was also examined. ETAF mimicked the stimulatory effect of IL-1 on LC T6E, while BP depressed T6E in a manner resembling that seen with ILS. No agents altered Class II (DR and DQ) expression by LC. BP was a specific IL-1 inhibitor, and did not inhibit thymocyte proliferation in the standard IL-1 bioassay in the absence of IL-1. These results demonstrate that molecules resembling IL-1 or ILS can modulate T6E, and implicate locally produced ETAF and ILS in the regulation of T6E in the oral mucosa in vivo.
REFERENCES
- Bergstresser, P.R.; Toews, G.B.; and Streilein, J.W. (1980): Natural and Perturbed Distributions of Langerhans Cells: Responses to Ultraviolet Light, Heterotopic Skin Grafting, and Dinitrofluorobenzene Sensitization, J Invest Dermatol 75:73-77.
- Dewhirst, F.E.; Stashenko, P.P.; Mole, J.E.; and Tsu-Rumachi, T. (1985): Purification and Partial Sequence of Human Osteoclast Activating Factor: Identity with Interleukin 1, J Immunol 135:2562-2568.[Abstract]
- Gowen, M.; Wood, D.D.; Thrie, E.J.; McGuire, M.K.B.; and Russell, R.G.G. (1983): An Interleukin I Like Factor Stimulates Bone Resorption in vitro, Nature 306:378-380.[CrossRef][Medline]
[Order article via Infotrieve]
- Lander, P.E.; Seymour, G.J.; Masci, P.; and Powell, R.N. (1986): The Extraction and Purification of a Murine Bone Regulatory Protein, J Dent Res 65:479, Abst. No. 69.
- Liao, Z.; Grimshaw, R.S.; and Rosenstreich, D.L. (1984): Identification of a Specific Interleukin-1 Inhibitor in the Urine of Febrile Patients, J Exp Med 159:126-136.[Abstract/Free Full Text]
- Luger, T.A.; Stadler, B.M.; Luger, B.M.; Mathieson, B.J.; Mage, M.; Schmidt, J.A.; and Oppenheim, J.J. (1982): Murine Epidermal Cell-derived Thymocyte-activating Factor Resembles Murine Interleukin 1, J Immunol 128:2147-2152.[Abstract]
- Luger, T.A.; Charon, J.A.; Colot, M.; Mickshe, M.; and Oppenheim, J.J. (1983): Chemotactic Properties of Partially Purified Human Epidermal Cell-derived Thymocyte-activating Factor (ETAF) for Polymorphonuclear and Mononuclear Cells, J Immunol 131:816-820.[Abstract]
- Luger, T.A.; Kock, A.; and Danner, M. (1985a): Characterization of Immunoregulatory Cytokines Produced by Epidermal Cells, Scand J Immunol 21:455-462.[Medline]
[Order article via Infotrieve]
- Luger, T.A.; Wirth, U.; and Kock, A. (1985b): Epidermal Cells Synthesize a Cytokine with Interleukin 3-like Properties, J Immunol 134:915-919.[Abstract]
- Mannel, D.N.; Mizel, S.B.; Diamenstein, T.; and Falk, W. (1985): Induction of Interleukin 2 Responsiveness in Thymocytes by Synergistic Action of Interleukin-1 and Interleukin-2, J Immunol 134:3108-3110.[Medline]
[Order article via Infotrieve]
- Mizel, S.B.; Oppenheim, J.J.; and Rosenstreich, D.L. (1978): Characterization of Lymphocyte-activating Factor (LAF) Produced by a Macrophage Cell Line, P388D1. II. Biochemical Characterization of LAF Induced by Activated T Cells and LPS, J Immunol 120:1504-1508.[Abstract/Free Full Text]
- Murphy, G.F.; Bhan, A.K.; Sato, S.; Harrist, T.J.; and Mihm, M.C. (1981): Characterization of Langerhans Cells by the Use of Monoclonal Antibodies, Lab Invest 45:465-468.[Medline]
[Order article via Infotrieve]
- Murphy, G.F. (1982): Monoclonal Anti-T6 Antibody and Langerhans Cells, Br J Dermatol 107:487-489.[CrossRef][Medline]
[Order article via Infotrieve]
- Oppenheim, J.J.; Kovacs, E.J.; Matsushima, K.; and Durum, S.K. (1986): There is More Than One Interleukin 1, Immunol Today 7:45-56.[CrossRef]
- Sauder, D.N.; Dinarello, C.A.; and Morhenn, V.B. (1984): Langerhans Cell Production of Interleukin-1, J Invest Dermatol 82:605-607.[CrossRef][Medline]
[Order article via Infotrieve]
- Scala, G.; Kuang, Y.D.; Hall, R.E.; Muchmore, A.V.; and Oppenheim, J.J. (1984): Accessory Cell Function of Human B Cells. I. Production of Both Interleukin 1-like Activity and an Interleukin 1 Inhibitory Factor by an EBV-Transformed Human B Cell Line, J Exp Med 159:1637-1652.[Abstract/Free Full Text]
- Smith, K.A.; Lachman, L.B.; Oppenheim, J.J.; and Favata, M.F. (1980): The Functional Relationship of the Interleukins, J Exp Med 151:1551-1556.[Abstract/Free Full Text]
- Stingl, G.; Katz, S.I.; Green, I.; and Shevach, E.M. (1980): The Functional Role of Langerhans Cells, J Invest Dermatol 74:315-318.[CrossRef][Medline]
[Order article via Infotrieve]
- Walsh, L.H.; Powell, R.N.; Seymour, G.J.; and New-Comb, G.M. (1984): Loss of Langerhans Cells from Gingival Tissue Maintained in Organ Culture, J Oral Pathol 13:604-613.[CrossRef][Medline]
[Order article via Infotrieve]
- Walsh, L.J.; Seymour, G.J.; and Powell, R.N. (1985): The in vitro Effect of Retinol on Human Gingival Epithelium. II. Modulation of Langerhans Cell Markers and Interleukin-1 Production, J Invest Dermatol 85:501-506.[CrossRef][Medline]
[Order article via Infotrieve]
- Walsh, L.J.; Seymour, G.J.; and Powell, R.N. (1986a): Modulation of Gingival Langerhans Cell T6 Antigen Expression in vitro by Interleukin-1 and an IL-1 Inhibitor, Clin Exp Immunol 64:334-341.[Medline]
[Order article via Infotrieve]
- Walsh, L.J.; Seymour, G.J.; and Powell, R.N. (1986b): Modulation of Langerhans Cell T6 Antigen Expression by Interleukin-1, J Dent Res 65:473, Abst. No. 14.
- Walsh, L.J.; Seymour, G.J.; and Powell, R.N. (1986c): Modulation of Class II (DR and DQ) Antigen Expression on Gingival Langerhans Cells in vitro by Gamma Interferon and Prostaglandin E2, J Oral Pathol 15:347-351.[CrossRef][Medline]
[Order article via Infotrieve]
- Walsh, L.K.; Seymour, G.J.; and Savage, N.W. (1986d): Oral Mucosal Langerhans Cells Express DR and DQ Antigens, J Dent Res 65:390-393.[Abstract/Free Full Text]
- Walsh, L.J.; Seymour, G.J.; and Powell, R.N. (1986e): Interleukin-1 Modulates T6 Expression on a Putative Intraepithelial Langerhans Cell Precursor Population, J Dent Res 65:1424-1426.[Abstract/Free Full Text]
- Wynne, S.E.; Walsh, L.J.; Seymour, G.J.; and Powell, R.N. (1986): In situ Identification of Natural Killer (NK) Cells in Human Gingival Tissues, J Periodontol (in press).
Journal of Dental Research, Vol. 66, No. 3,
766-769 (1987)
DOI: 10.1177/00220345870660031201

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A.W. Barrett, A.T. Cruchley, and D.M. Williams
Oral Mucosal Langerhans' Cells
Critical Reviews in Oral Biology & Medicine,
January 1, 1996;
7(1):
36 - 58.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|